Form 8-K - Current report:
SEC Accession No. 0001493152-25-003019
Filing Date
2025-01-21
Accepted
2025-01-21 16:05:12
Documents
14
Period of Report
2025-01-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47552
2 ex10-1.htm EX-10.1 28469
  Complete submission text file 0001493152-25-003019.txt   253406

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE idxg-20250114.xsd EX-101.SCH 3018
4 XBRL LABEL FILE idxg-20250114_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE idxg-20250114_pre.xml EX-101.PRE 24167
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3477
Mailing Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054
Business Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Filer) CIK: 0001054102 (see all company filings)

EIN.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24249 | Film No.: 25542524
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)